Tick-borne Diseases
8
4
4
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Human Immune Response to Ixodes Scapularis Tick Bites
SWEtick - a Prospective Multicenter Study of Tick-borne Diseases in Sweden
Navigating Pregnancy and Parenthood With Lyme Disease
Fever After Tick Bite Study
Insights Into Tick-Borne Diseases: a Study From an Endemic Area of Northern Italy
Tick-borne Illness and Clothing Study of Rhode Island
Clinical Research for the Diagnosis of Tick-borne Diseases in Patients With Unexplained Acute Fever
Lyme Disease Prevention Program